ADVERTISEMENT
India’s PLI Scheme To Boost Bulk Drug Output Faces These Hurdles
Here’s what may deter Indian drugmakers from investing under incentive scheme.
04 Jan 2021, 07:49 AM IST
India's scheme offering incentives to boost local capacity of pharma ingredients has received a good response in certain categories. Yet, companies and analysts cite multiple hurdles from huge capital expenditure to India's bureaucratic hurdles.The government received 200 applications, according to RK Baheti, chief financial officer at Alembic Pharma Ltd., one of the applicants. The government is trying to bridge the gap between dome...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT